NO164473C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-pyridylmethyl-thio- og -sulfinylbenzimidazoler. - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-pyridylmethyl-thio- og -sulfinylbenzimidazoler.

Info

Publication number
NO164473C
NO164473C NO844836A NO844836A NO164473C NO 164473 C NO164473 C NO 164473C NO 844836 A NO844836 A NO 844836A NO 844836 A NO844836 A NO 844836A NO 164473 C NO164473 C NO 164473C
Authority
NO
Norway
Prior art keywords
pyridylmethyl
thio
preparation
therapeutically active
analogue procedure
Prior art date
Application number
NO844836A
Other languages
English (en)
Other versions
NO164473B (no
NO844836L (no
Inventor
John Charles Sih
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO844836L publication Critical patent/NO844836L/no
Publication of NO164473B publication Critical patent/NO164473B/no
Publication of NO164473C publication Critical patent/NO164473C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO844836A 1983-12-05 1984-12-04 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-pyridylmethyl-thio- og -sulfinylbenzimidazoler. NO164473C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55808783A 1983-12-05 1983-12-05
US06/648,118 US4575554A (en) 1983-12-05 1984-09-06 Substituted 2-pyridylmethylthio- and sulfinyl-benzimidazoles as gastric antisecretory agents

Publications (3)

Publication Number Publication Date
NO844836L NO844836L (no) 1985-06-06
NO164473B NO164473B (no) 1990-07-02
NO164473C true NO164473C (no) 1990-10-10

Family

ID=27071629

Family Applications (1)

Application Number Title Priority Date Filing Date
NO844836A NO164473C (no) 1983-12-05 1984-12-04 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-pyridylmethyl-thio- og -sulfinylbenzimidazoler.

Country Status (16)

Country Link
US (1) US4575554A (no)
EP (1) EP0150586B1 (no)
JP (1) JPS60139689A (no)
KR (1) KR890000382B1 (no)
AU (1) AU571907B2 (no)
DE (1) DE3484565D1 (no)
DK (1) DK577584A (no)
ES (1) ES8603711A1 (no)
FI (1) FI83418C (no)
GR (1) GR81143B (no)
IE (1) IE58431B1 (no)
IL (1) IL73433A (no)
MX (1) MX160796A (no)
NO (1) NO164473C (no)
NZ (1) NZ210135A (no)
PH (1) PH19962A (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2161160B (en) * 1984-07-06 1989-05-24 Fisons Plc Heterocyclic sulphinyl compounds
JPS6150979A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
EP0178438A1 (en) * 1984-09-19 1986-04-23 Beecham Group Plc Novel compounds
KR890000387B1 (ko) * 1984-09-24 1989-03-16 디 엎존 캄파니 2-(피리딜알켄술 피닐)벤즈 이미드아졸류의 n-치환 유도체의 제조방법
JO1406B1 (en) * 1984-11-02 1986-11-30 سميث كلاين اند فرينش لابوراتوريز ليمتد Chemical compounds
US4743609A (en) * 1985-02-12 1988-05-10 Banyu Pharmaceutical Co., Ltd. Indole derivatives having gastric and antisecretory and cytoprotective properties, and pharmaceutical preparations containing same
ES2032394T3 (es) * 1986-02-20 1993-02-16 Hoechst Aktiengesellschaft Procedimiento para preparar derivados de tienoimidazol sustituidos.
WO1987005296A1 (en) * 1986-03-07 1987-09-11 Pfizer Inc. 2-[(2-pyridyl)methylsulfinyl]thienoimidazoles and related compounds as antiulcer agents
US4772619A (en) * 1986-07-17 1988-09-20 G. D. Searle & Co. [(1H-benzimidazol-2-ylsulfinyl)methyl]-2-pyridinamines
AU3683889A (en) * 1988-06-30 1990-01-23 Upjohn Company, The Transdermal antisecretory agents for gastrointestinal disease
US4965269A (en) * 1989-12-20 1990-10-23 Ab Hassle Therapeutically active chloro substituted benzimidazoles
EP0673246A1 (de) * 1992-12-10 1995-09-27 Byk Gulden Lomberg Chemische Fabrik GmbH Verwendung von alkylthiopyridinen zur bekämpfung von heliobacter-bakterien
UA32583C2 (uk) * 1993-06-29 2001-02-15 Бік Гульден Ломберг Хеміше Фабрік Гмбх Похідні арилтіоалкілтіопіридину
NZ288608A (en) * 1994-06-10 1999-01-28 Byk Gulden Lomberg Chem Fab Substituted pyridinylmethyl-thio(or sulphinyl)-benzimidazole(or 1h-imidazo-[2,3-b]-pyridine) and medicaments to combat heliobacter bacteria
PT1308159E (pt) * 1995-09-21 2005-02-28 Pharma Pass Ii Llc Composicao farmaceutica contendo um omeprazole labil a acidos e processo para a sua preparacao
US6245913B1 (en) 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
WO2002026210A2 (en) * 2000-09-29 2002-04-04 Geneva Pharmaceuticals Inc. Proton pump inhibitor formulation
US20030228363A1 (en) * 2002-06-07 2003-12-11 Patel Mahendra R. Stabilized pharmaceutical compositons containing benzimidazole compounds
US20060024362A1 (en) 2004-07-29 2006-02-02 Pawan Seth Composition comprising a benzimidazole and process for its manufacture
CA3207747A1 (en) * 2016-09-14 2018-03-22 Yufeng Jane Tseng Novel substituted benzimidazole derivatives as d-amino acid oxidase (daao) inhibitors
CN112142653B (zh) * 2020-10-22 2022-02-11 成都百泉生物医药科技有限公司 奥美拉唑中间体的制备方法
WO2025085783A1 (en) * 2023-10-20 2025-04-24 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Prazole-based antiviral therapeutics

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE418966B (sv) * 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
ZA825106B (en) * 1981-08-13 1983-04-27 Haessle Ab Novel pharmaceutical compositions
US4472409A (en) * 1981-11-05 1984-09-18 Byk Gulden Lomberg Chemische Fabrik Gesellschaft Mit Beschrankter Haftung 2-Pyridylmethyl thio(sulfinyl)benzimidazoles with gastric acid secretion inhibiting effects
ZA828136B (en) * 1981-11-05 1983-09-28 Byk Gulden Lomberg Chem Fab Substituted benzimidazoles,a process for their preparation,their use,and medicaments containing them
DE3216843C2 (de) * 1982-05-05 1986-10-23 Ludwig Heumann & Co GmbH, 8500 Nürnberg 3-Thiomethyl-pyridin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
SE8300736D0 (sv) * 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds

Also Published As

Publication number Publication date
DK577584A (da) 1985-06-06
KR850004483A (ko) 1985-07-15
FI844755A0 (fi) 1984-12-03
FI83418C (fi) 1991-07-10
AU3564384A (en) 1985-06-13
DE3484565D1 (de) 1991-06-13
AU571907B2 (en) 1988-04-28
GR81143B (en) 1985-04-04
DK577584D0 (da) 1984-12-04
NO164473B (no) 1990-07-02
KR890000382B1 (ko) 1989-03-15
EP0150586A3 (en) 1985-08-28
JPS60139689A (ja) 1985-07-24
IL73433A (en) 1988-11-30
IL73433A0 (en) 1985-02-28
IE843095L (en) 1985-06-05
ES8603711A1 (es) 1986-01-16
ES538249A0 (es) 1986-01-16
NZ210135A (en) 1989-01-06
JPH0572392B2 (no) 1993-10-12
MX160796A (es) 1990-05-22
EP0150586B1 (en) 1991-05-08
FI844755L (fi) 1985-06-06
IE58431B1 (en) 1993-09-22
EP0150586A2 (en) 1985-08-07
US4575554A (en) 1986-03-11
NO844836L (no) 1985-06-06
FI83418B (fi) 1991-03-28
PH19962A (en) 1986-08-20

Similar Documents

Publication Publication Date Title
NO164473C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-pyridylmethyl-thio- og -sulfinylbenzimidazoler.
NO159016C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenetanolaminderivater.
NO163691C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-acryl-piperazinalkanamider.
NO872946D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzensulfonamidoindanylforbindelser.
NO160521C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner.
NO894842L (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazoler.
NO162113C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenetanolaminforbindelser.
NO870240D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tieno-1,4-diazepiner.
NO162858C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive thiazolidinderivater.
NO165841C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive heteroaryl-3-okso-propannitril-derivater.
NO166083C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridazodiazepinderivater.
NO161317C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oksikamer.
NO158534C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenoksyalkylkarboksylsyrederivater.
NO159930C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater.
NO158460C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO169963C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive, substituerte 3,4-dihydro-2h-benzopyraner
NO163775C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isoindolinyl-alkyl-piperaziner.
NO157538C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzothiazolsufonamidderivater.
NO158673C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater.
NO163330C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive isokinolinderivater.
NO304428B1 (no) AnalogifremgangsmÕte for fremstilling av terapeutisk aktive vinylazoler
NO168530C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzoksazoninforbindelser.
NO155842C (no) Analogifremgangsmaate ved fremstilling av terapeutiske aktive 2-beta-d-ribofuranosylselenazol-4-carboxamider.
NO157934C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive antracyklinglykosider.
NO156408C (no) AnalogifremgangsmŸte for fremstilling av terapeutisk aktive l-prolinderivater.